RICHMOND HILL, ONTARIO--(Marketwired - Dec. 12, 2017) - Helix BioPharma Corp. (TSX:HPB)(FRANKFURT:HBP) ("Helix"), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, announced today the results of matters ...
more»